Found: 33
Select item for more details and to access through your institution.
The prognostic value of PI3K mutational status in breast cancer: A meta‐analysis.
- Published in:
- Journal of Cellular Biochemistry, 2018, v. 119, n. 6, p. 4287, doi. 10.1002/jcb.26687
- By:
- Publication type:
- Article
ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins.
- Published in:
- Cells (2073-4409), 2021, v. 10, n. 7, p. 1659, doi. 10.3390/cells10071659
- By:
- Publication type:
- Article
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression.
- Published in:
- Oncogene, 2002, v. 21, n. 27, p. 4328, doi. 10.1038/sj.onc.1205594
- By:
- Publication type:
- Article
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 1, p. 23, doi. 10.1002/ijc.11496
- By:
- Publication type:
- Article
Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study.
- Published in:
- Cell Death & Disease, 2019, v. 10, n. 7, p. N.PAG, doi. 10.1038/s41419-019-1770-3
- By:
- Publication type:
- Article
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling.
- Published in:
- Carcinogenesis, 2006, v. 27, n. 5, p. 1047, doi. 10.1093/carcin/bgi287
- By:
- Publication type:
- Article
Author Correction: Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
- Published in:
- Nature Communications, 2018, v. 9, p. 16187, doi. 10.1038/ncomms16187
- By:
- Publication type:
- Article
Somatic chromosomal engineering identifies BCAN-NTRK1 as a potent glioma driver and therapeutic target.
- Published in:
- Nature Communications, 2017, v. 8, n. 7, p. 15987, doi. 10.1038/ncomms15987
- By:
- Publication type:
- Article
Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14292, doi. 10.1038/ncomms14292
- By:
- Publication type:
- Article
P-selectin is a nanotherapeutic delivery target in the tumor microenvironment.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 345, p. 1, doi. 10.1126/scitranslmed.aaf7374
- By:
- Publication type:
- Article
Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns.
- Published in:
- Genome Medicine, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13073-020-00774-x
- By:
- Publication type:
- Article
Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 8, p. 628, doi. 10.1093/jnci/djk134
- By:
- Publication type:
- Article
Antitumor activity of the PI3K δ-sparing inhibitor MEN1611 in PIK3CA mutated, trastuzumab-resistant HER2 + breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2023, v. 199, n. 1, p. 13, doi. 10.1007/s10549-023-06895-2
- By:
- Publication type:
- Article
Effect of p95HER2/611CTF on the Response toTrastuzumab and Chemotherapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 11, p. 1, doi. 10.1093/jnci/dju291
- By:
- Publication type:
- Article
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Solid pseudopapillary neoplasms of the pancreas are dependent on the Wnt pathway.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 8, p. 1684, doi. 10.1002/1878-0261.12490
- By:
- Publication type:
- Article
High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 1, p. 138, doi. 10.1016/j.molonc.2015.09.002
- By:
- Publication type:
- Article
Potential biomarkers of long-term benefit from single-agent trastuzumab or lapatinib in HER2-positive metastatic breast cancer.
- Published in:
- Molecular Oncology, 2014, v. 8, n. 1, p. 20, doi. 10.1016/j.molonc.2013.08.013
- By:
- Publication type:
- Article
Green tea catechins suppress the DNA synthesis marker MCM7 in the TRAMP model of prostate cancer
- Published in:
- Molecular Oncology, 2007, v. 1, n. 2, p. 196, doi. 10.1016/j.molonc.2007.05.007
- By:
- Publication type:
- Article
Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 9, p. 1413, doi. 10.2967/jnumed.115.169417
- By:
- Publication type:
- Article
Biomarkers of drugs targeting HER-family signalling in cancer.
- Published in:
- Journal of Pathology, 2014, v. 232, n. 2, p. 219, doi. 10.1002/path.4269
- By:
- Publication type:
- Article
Somatic PIK3CA mutations as a driver of sporadic venous malformations.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 332, p. 1, doi. 10.1126/scitranslmed.aaf1164
- By:
- Publication type:
- Article
Biosynthesis of tumorigenic HER2 C-terminal fragments by alternative initiation of translation.
- Published in:
- EMBO Journal, 2006, v. 25, n. 13, p. 3234, doi. 10.1038/sj.emboj.7601191
- By:
- Publication type:
- Article
RSK3/4 mediate resistance to PI3K pathway inhibitors in breast cancer.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 6, p. 2551, doi. 10.1172/JCI66343
- By:
- Publication type:
- Article
First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.744112
- By:
- Publication type:
- Article
Quantification of HER family receptors in breast cancer.
- Published in:
- Breast Cancer Research, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13058-015-0561-8
- By:
- Publication type:
- Article
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 3, p. 1, doi. 10.1186/bcr2888
- By:
- Publication type:
- Article
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silicobased mechanism.
- Published in:
- Breast Cancer Research, 2011, v. 13, n. 1, p. 1, doi. 10.1186/bcr2888
- By:
- Publication type:
- Article
Synergy between trastuzumab and pertuzumab for human epidermal growth factor 2 (Her2) from colocalization: an in silico based mechanism.
- Published in:
- 2011
- By:
- Publication type:
- journal article
CDK 4/6 Inhibition Overcomes Acquired and Inherent Resistance to PI3Kα Inhibition in Pre-Clinical Models of Head and Neck Squamous Cell Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3214, doi. 10.3390/jcm9103214
- By:
- Publication type:
- Article
How a new drug is born.
- Published in:
- European Heart Journal, 2021, v. 42, n. 32, p. 3039, doi. 10.1093/eurheartj/ehab076
- By:
- Publication type:
- Article
Recurrence biomarkers of triple negative breast cancer treated with neoadjuvant chemotherapy and anti-EGFR antibodies.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00334-5
- By:
- Publication type:
- Article
MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 3, p. 748, doi. 10.1002/ijc.32170
- By:
- Publication type:
- Article